Treatment of ventricular arrhythmias with mexiletine (Kö 1173).
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D055598:Chemical Phenomena; D002621:Chemistry; D004562:Electrocardiography; D006352:Heart Ventricles; D006801:Humans; D007275:Injections, Intravenous; D008012:Lidocaine / Q000008:administration & dosage / Q000097:blood; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D010636:Phenols / Q000008:administration & dosage / Q000627:therapeutic use; D011437:Propylamines / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use*; D013610:Tachycardia / Q000188:drug therapy; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D010636:Phenols; D011437:Propylamines; D008012:Lidocaine